|Bid||364.46 x 800|
|Ask||364.79 x 1200|
|Day's Range||363.17 - 370.00|
|52 Week Range||312.33 - 449.38|
|Beta (5Y Monthly)||1.19|
|PE Ratio (TTM)||61.64|
|Earnings Date||Oct 27, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||1.36 (0.35%)|
|Ex-Dividend Date||Aug 13, 2021|
|1y Target Est||462.55|
WAYNE, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, October 28, 2021. To register for the conference call and receive dial-in information, please use the following link: http://www.directeventreg.com/registration/event/4079822. The call can also be accessed through a live audio webcast on the company’s website teleflex.com.
Teleflex (NYSE:TFX) has had a rough three months with its share price down 5.2%. However, stock prices are usually...
Late-Breaking Data Presentation Reveals How UroLift PUL’s Post-Operative Events Compare With Other Minimally Invasive Procedures and Traditional Surgery for the Treatment of BPHWAYNE, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that new real-world healthcare claims data reveal that the risk of return procedures is lowest after treatment with the UroLift® System among the analyzed benign prostatic hyperplasia (BPH) treatment options. The data also show